- The trend backdrop is active with a 64-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
CSN
LSE
Week ended 31 Jul 2026
Weekly Investor Report
Chesnara plc · Financial Services · Insurance - Life
Latest close
344.0 GBP
1.0%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 9.1% above the Trend Line and sits at 93.5% of its 52-week range. The latest completed week returned 1.0%, after a 2.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 53/100. Near-term considerations: price is close to its 52-week high.
Setup score
68
out of 100
Latest Close
344.0 GBP
31 Jul 2026
1W Return
1.0%
latest completed week
4W Return
2.1%
short-term follow-through
12W Return
10.1%
quarterly tape
Trend Breadth
100.0%
52 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.0%
Latest completed week; four-week move 2.1%.
Indicator stack
100/70
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
10 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 9.1% above the Trend Line and sits at 93.5% of its 52-week range. The latest completed week returned 1.0%, after a 2.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9312-week average 0.72
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.93Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.1% over four weeks, 10.1% over 12 weeks, and 32.4% over one year. The current trend has remained active for 64 consecutive weeks.
Performance by holding period
Active trend streak64 weeks
Active weeks in one year52
Trend breadth100.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.99Latest activity-pressure read.
Pressure change30.0%Four-week change in activity pressure.
Leadership5.72Latest relative-leadership reading.
RS change-7.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 76%
Model confidence 62%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength17/100Blend of value, momentum, and quality. Underlying universe rank 84; rank 1 is best.
Value11/100Relative valuation strength. Underlying universe rank 90; rank 1 is best.
Quality2/100Profitability and accounting quality. Underlying universe rank 99; rank 1 is best.
Momentum91/100Medium-term price momentum. Underlying universe rank 10; rank 1 is best.
Growth6/100Revenue and earnings growth. Underlying universe rank 95; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.9x Market value relative to trailing revenue.
- EV / EBITDA
- 17.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -26.1% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- 3.4% Operating profit retained from revenue.
- Free-cash-flow margin
- -24.6% Free cash flow generated from revenue.
- Return on invested capital
- 3.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -41.7% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -618.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 1/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 6.6% Cash dividends relative to market value.
- Buyback yield
- -17.2% Net share repurchases relative to market value.
- Shareholder yield
- -10.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 10 relevant articles.
2 positive · 7 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.7%Distance below the 52-week high.
13-week volatility1.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher16 of 268 weeks finished lower.
Best week+6.8%Week of 17 Apr.
Worst week-8.3%Week of 13 Mar.
Latest week+1.0%Week of 31 Jul.
Shape of recent returns
Strong gains2
Modest gains14
Flat weeks2
Modest losses7
Sharp losses1
Recent vol1.5%13-week weekly-return volatility.
Base vol2.7%52-week weekly-return volatility.
Up/down split30/20Count of positive and negative weeks in the 52-week window.
Average skew2.2% / -1.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Financial Services
4-week rank28 / 100
Group average-0.5%
Trend breadth62.0%
Trend62.0%active weekly trend signals
MD65.0%positive activity pressure
RS46.0%positive relative leadership
Four-week leaders
IndustryGB Insurance - Life
4-week rank3 / 4
Group average3.3%
Trend breadth75.0%
Trend75.0%active weekly trend signals
MD50.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape71/100
Trend, activity pressure, participation, and risk combine to a 71/100 tape read.
Indicator analysis79/100Latest 12-week confirmation: trend 12/12, activity pressure 8/12, relative leadership 12/12.
Activity pressure 0.93; 2 reversal markers Factors27/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 97; Small Cap Core rank 74 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 10 relevant articles.
REG - Chesnara PLC - Director/PDMR Shareholding Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 344.0 GBP | 1.0% | 315.3 GBP | 252.3 GBP | 0.99 | 5.72 | 2.0M | On |
| 24 Jul 2026 | 340.5 GBP | 2.3% | 313.7 GBP | 251.7 GBP | 0.98 | 6.15 | 2.1M | On |
| 17 Jul 2026 | 333.0 GBP | 0.0% | 312.2 GBP | 251.0 GBP | 0.95 | 5.28 | 1.2M | On |
| 10 Jul 2026 | 333.0 GBP | -1.2% | 310.5 GBP | 250.4 GBP | 0.99 | 6.49 | 3.1M | On |
| 3 Jul 2026 | 337.0 GBP | 0.1% | 308.8 GBP | 249.8 GBP | 0.76 | 6.19 | 1.9M | On |
| 26 Jun 2026 | 336.5 GBP | 0.6% | 307.1 GBP | 249.1 GBP | 0.41 | 7.90 | 449.6K | On |
| 19 Jun 2026 | 334.5 GBP | 2.0% | 304.9 GBP | 248.4 GBP | 0.19 | 8.92 | 948.7K | On |
| 12 Jun 2026 | 328.0 GBP | 3.3% | 303.0 GBP | 247.9 GBP | 0.01 | 5.95 | 687.8K | On |
| 5 Jun 2026 | 317.5 GBP | -1.7% | 301.3 GBP | 247.3 GBP | -0.03 | 3.75 | 232.2K | On |
| 29 May 2026 | 323.0 GBP | -0.8% | 299.8 GBP | 246.8 GBP | -0.04 | 5.31 | 1.5M | On |
| 22 May 2026 | 325.5 GBP | 1.1% | 298.3 GBP | 246.3 GBP | -0.17 | 5.74 | 3.1M | On |
| 15 May 2026 | 322.0 GBP | 3.0% | 296.4 GBP | 245.8 GBP | -0.38 | 7.59 | 3.0M | On |
| 8 May 2026 | 312.5 GBP | 1.0% | 294.8 GBP | 245.3 GBP | -0.48 | 4.29 | 1.8M | On |
| 1 May 2026 | 309.5 GBP | 1.3% | 293.5 GBP | 244.8 GBP | -0.58 | 2.25 | 1.6M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.